Growth Metrics

Viemed Healthcare (VMD) Common Equity (2018 - 2026)

Viemed Healthcare filings provide 8 years of Common Equity readings, the most recent being $141.5 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 6.18% to $141.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $141.5 million, a 6.18% increase, with the full-year FY2025 number at $141.5 million, up 6.18% from a year prior.
  • Common Equity hit $141.5 million in Q4 2025 for Viemed Healthcare, up from $133.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $141.6 million in Q2 2025 to a low of $83.4 million in Q1 2021.
  • Median Common Equity over the past 5 years was $106.7 million (2023), compared with a mean of $110.6 million.
  • Biggest five-year swings in Common Equity: soared 70.96% in 2021 and later grew 2.4% in 2022.
  • Viemed Healthcare's Common Equity stood at $94.8 million in 2021, then rose by 2.4% to $97.1 million in 2022, then increased by 17.3% to $113.9 million in 2023, then increased by 17.04% to $133.3 million in 2024, then increased by 6.18% to $141.5 million in 2025.
  • The last three reported values for Common Equity were $141.5 million (Q4 2025), $133.6 million (Q3 2025), and $141.6 million (Q2 2025) per Business Quant data.